Managers
Adarza BioSystems has closed a USD5 million Series B financing. Proceeds from the financing will be used to expand production capacity in its St Peters, MO manufacturing facility and launch its first immunoassay product consumable and instrument platform.
Proceeds will also be used to accelerate development of highly sensitive assays targeting a variety of biological analytes including cytokines, antigens and small molecules. Adarza’s Arrayed Imaging Reflectometry (AIR-StripTM) will bring an unprecedented combination of performance, workflow benefits with high sensitivity, broad dynamic range, precision, assay robustness to both life science and drug development researchers as well as clinical diagnostics practitioners.
Sverica Capital Management has held the final close of its fourth private equity fund, Sverica Capital Partners Fund IV LP, which exceeded its original target, was oversubscribed and closed at its hard cap of USD275 million.
Sverica will use Fund IV to continue its strategy of investing in growing business and IT services, healthcare services and high value industrial companies that have the potential to be category leaders in their respective industries.
Dave Finley, Managing Director of Sverica, says: “We appreciate the strong support shown for Fund IV from new and key existing investors. We believe the fundraise validates Sverica’s
Spectral Edge has completed an oversubscribed GBP1.5 million second funding round. New lead investors IQ Capital and Parkwalk Advisors, along with angel investors from Cambridge Angels, Wren Capital, Cambridge Capital Group and Martlet, the Marshall of Cambridge Corporate Angel investment fund, join the Rainbow Seed Fund/Midven and Iceni in backing the company.
Spun out of the University of East Anglia (UEA) Colour Lab, Spectral Edge has developed innovative image fusion technology. This combines different types of image, ranging from the visible to invisible (such as infrared and thermal), to enhance detail, aid visual accessibility, and create ever more beautiful pictures.
Gimv today announces a EUR 4 million investment in Topas Therapeutics, a biopharma company developing a unique immunotherapy approach to treat autoimmune diseases.
This investment is part of a total Series A financing round of EUR 14 million from a consortium of specialised life sciences investors including Epidarex Capital, EMBL Ventures and Evotec AG.
Topas Therapeutics, based in Hamburg (Germany), has developed a unique technology for the induction of antigen-specific immune tolerance. This new approach has the potential to treat autoimmune diseases, allergies and drug induced immune reactions in a more efficient and safe way. The funds will be used
Asure Software has acquired Mangrove Employer Services, a Tampa, Florida-based cloud SaaS vendor in Human Capital Management (HCM) applications.
The company develops, and implements HR, Payroll, Benefits, and Talent Management software solutions. Mangrove’s HCM suite of solutions is designed to be easy-to-use, with fully integrated HR/payroll applications to help companies recruit, manage, pay, and analyse their workforce more effectively.
The acquisition enables Asure Software to alter the marketplace of Human Capital Management by offering a comprehensive solution that brings workforce and workspace management together. These two workflows combined in one unified management platform increases company bottom-line performance through greater employee
AITV, a US-based venture capital firm that invests in early-stage and medium-growth software companies, has made a follow-on investment in LiveAction's recent USD36 million Series B financing, alongside Insight Venture Partners and Cisco Investments.
As part of the investment, founding general partner, Bill Malloy, joins the LiveAction board as an observer, alongside already presiding board member and founding general partner, Brian Nugent. The funding proceeds will allow LiveAction to focus on expanding operations globally and accelerate feature product development, further establishing the company as the visibility software standard for the Forbes Global 2000.
"Our follow-on capital into LiveAction not only
William Blair, a global investment banking and asset management firm, has formed a strategic alliance with Allier Capital, an Australia-based independent financial advisory firm.
As part of the strategic cooperation, William Blair and Allier Capital will offer clients in Australia access to a range of investment banking services in global markets, including public offerings in the U.S. securities markets, mergers and acquisitions, advisory services, and private placements, among others.
“After working with Allier for the last couple of years, we are delighted to formalise our relationship,” says Brent Gledhill, global head of Investment Banking at William Blair. “This partnership
Teralys Capital has held the final closing of the significantly oversubscribed USD375 million Teralys Capital Innovation Fund (the fund).
Teralys' most recent fund of funds was created under the Government of Canada's Venture Capital Action Plan (VCAP) in collaboration with the Government of Québec as well as leading Canadian and International institutional investors.
Teralys Capital Innovation Fund is backed by: (i) leading Canadian and international institutional investors such as Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ, Investissement Québec, BDC Capital, Fondaction CSN, Fiera Capital, Lune Rouge, Bpifrance, National Bank of Canada, La Capitale, Desjardins Group and
Coherent is to acquire Rofin for USD32.50 per share in cash, in a transaction valued at approximately USD942 million.
The transaction is expected to close within six to nine months, subject to approval by Rofin stockholders, regulatory approvals in the US and other countries as well as other customary closing conditions.
A team from CMS Germany led by Frankfurt-based partner Dr Heike Wagner advised Coherent on the transaction. CMS has been a regular legal advisor to Coherent for many years and advised Coherent, among others, on the acquisitions of Lumera Laser GmbH and Innolight GmbH.
Founded in 1966, Coherent is
Black Swan has secures a strategic investment of GBP3 million (JPY500 million) led by Mitsui, that will help support the UK-headquartered advanced analytics and prediction business to continue on its rapid growth trajectory.
The investment allows Black Swan to accelerate development of its NEST platform and geographic expansion into the US and Japan.
In 2015 Black Swan was awarded Sunday Times UK No1 startup status.
Named after a statement of improbability “it’s about as likely as seeing a black swan” dating back to 16th Century London, the company finds correlations at the intersections of public and private data
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
